PDCD2L and cancer: In our study, PDCD2L expression is significant aberrant expressed in different immune subtypes of BLCA, BRCA, COAD, KICH, KIRC, KIRP, LGG, LIHC, LUAD, LUSC, OV, PAAD, PRAD, SARC, STAD, TGCT and UCEC, which suggested that PDCD2L might play an important role in cancer immune therapy.